These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 20704563)
1. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563 [TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase. Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells. Shum M; Houde VP; Bellemare V; Junges Moreira R; Bellmann K; St-Pierre P; Viollet B; Foretz M; Marette A J Biol Chem; 2019 Aug; 294(32):12250-12260. PubMed ID: 31243102 [TBL] [Abstract][Full Text] [Related]
4. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6. Rosner M; Schipany K; Hengstschläger M Amino Acids; 2012 Jun; 42(6):2251-6. PubMed ID: 21710263 [TBL] [Abstract][Full Text] [Related]
8. A new tool to dissect the function of p70 S6 kinase. Bilanges B; Vanhaesebroeck B Biochem J; 2010 Oct; 431(2):e1-3. PubMed ID: 20874709 [TBL] [Abstract][Full Text] [Related]
9. p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling. Abe Y; Yoon SO; Kubota K; Mendoza MC; Gygi SP; Blenis J J Biol Chem; 2009 May; 284(22):14939-48. PubMed ID: 19332537 [TBL] [Abstract][Full Text] [Related]
10. PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1. Park JS; Kang DH; Lee DH; Bae SH Biochem Biophys Res Commun; 2015 Oct; 466(3):499-504. PubMed ID: 26381178 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation. Lee SJ; Yang EK; Kim SG Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854 [TBL] [Abstract][Full Text] [Related]
12. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1. Najafov A; Sommer EM; Axten JM; Deyoung MP; Alessi DR Biochem J; 2011 Jan; 433(2):357-69. PubMed ID: 21087210 [TBL] [Abstract][Full Text] [Related]
13. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner. Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895 [TBL] [Abstract][Full Text] [Related]
14. The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury. Al-Ali H; Ding Y; Slepak T; Wu W; Sun Y; Martinez Y; Xu XM; Lemmon VP; Bixby JL J Neurosci; 2017 Jul; 37(30):7079-7095. PubMed ID: 28626016 [TBL] [Abstract][Full Text] [Related]
15. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
16. Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation. Hong S; Zhao B; Lombard DB; Fingar DC; Inoki K J Biol Chem; 2014 May; 289(19):13132-41. PubMed ID: 24652283 [TBL] [Abstract][Full Text] [Related]
17. Contribution of S6K1/MAPK signaling pathways in the response to oxidative stress: activation of RSK and MSK by hydrogen peroxide. Siebel A; Cubillos-Rojas M; Santos RC; Schneider T; Bonan CD; Bartrons R; Ventura F; Rodrigues de Oliveira J; Rosa JL PLoS One; 2013; 8(9):e75523. PubMed ID: 24058693 [TBL] [Abstract][Full Text] [Related]
18. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation. Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress. Doscas ME; Williamson AJ; Usha L; Bogachkov Y; Rao GS; Xiao F; Wang Y; Ruby C; Kaufman H; Zhou J; Williams JW; Li Y; Xu X Neoplasia; 2014 Oct; 16(10):824-34. PubMed ID: 25379019 [TBL] [Abstract][Full Text] [Related]
20. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase. Tang X; Wang L; Proud CG; Downes CP Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]